Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLII.a

Alveolar hemorrhage (AH), diffuse AH (DAH)

Publications

Schweigert M, Almeida AB

Life-threatening pulmonary haemorrhage during cryoballoon ablation for atrial fibrillation.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2018 10 01;54;789-791 — 2018 10 01 — 789-791

Aksu T, Ebru Golcuk S, Yalin K

Haemoptysis and pulmonary haemorrhage associated with cryoballoon ablation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2015 Aug;17;1240 — 2015 Aug — 1240

Martí-Almor J, Jauregui-Abularach ME, Benito B, Vallès E, Bazan V, Sánchez-Font A, Vollmer I, Altaba C, Guijo MA, Hervas M, Bruguera-Cortada J

Pulmonary hemorrhage after cryoballoon ablation for pulmonary vein isolation in the treatment of atrial fibrillation.

Chest 2014 Jan;145;156-157 — 2014 Jan — 156-157